ivonescimab
akesobio
['ivonescimab', 'sclc', 'nsclc', 'ak112', 'akeso']
akeso releases promising data of ivonescimab (pd-1/vegf bsabs, ak112) for advanced nsclc at asco 2022. click the link to find more details. 
We are dedicated to the research, development, manufacturing and commercialization of novel antibody drugs that are affordable to patients worldwide.
#9926.HK